Rx ATP Rx ATP

Is Your Regulatory Contact Data Putting You at Risk?

A recent review of 298 U.S. drug and medical device distributor regulatory registrations found that incorrect data on file made nearly 1 in 4 registrants impossible to reach.

A recent review of 298 U.S. drug and medical device distributor regulatory registrations found that incorrect data on file made nearly 1 in 4 registrants impossible to reach — a direct compliance violation regardless of how sound day-to-day operations are.

Regulatory agencies rely on the contact information registrants provide to deliver critical notices, schedule inspections, and communicate enforcement actions. When that data is incorrect — whether due to a bounced email address, an unmonitored forwarding rule, or a typographical error entered at registration — the registrant is effectively unreachable. Inaccurate contact data is not simply an administrative oversight; it constitutes a compliance violation in its own right, independent of how well day-to-day operations are managed. Consequences can include regulatory fines, license suspension, and full license revocation. Periodic audits of registration data, with documented review processes, are an essential component of any sound compliance program.

Learn more

Read More